There are two quantitative and objective criteria used for the assessment of biological behavior as cell proliferative markers: Ki-67 and p53, which are most actively studied in meningioma for monitoring tumor aggressiveness, and objectively predicting tumor behavior in clinical intervention (4). This evidence concerns the gene TP53 and meningioma.